NCT05743842View on ClinicalTrials.gov

TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning

NAActive, not recruitingINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

March 14, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Liver Cancer
Interventions
DEVICE

TriSalus™ TriNav™Infusion System

Given by Infusion

DIAGNOSTIC_TEST

Angiogram

X-ray photograph

PROCEDURE

Y90-radioembolization procedure

procedure

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

TriSalus Life Sciences, Inc.

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER